Characteristics of Nationwide Urinary Tract Infection (UTI) Visits by Age and Type II Diabetes Status in Women

por Papp, Sara B, Christie, Alana L, Zimmern, Philippe E
Publicado 2023

Weight changes and patterns of weight measurements in hospitalized burn patients: a contemporary analysis

por Mendez-Romero, Denisse, Clark, Audra T, Christie, Alana, Wolf, Steven E
Publicado 2018

Cranberry Supplement, D-Mannose, and Other OTC Modalities for Prevention of Recurrent UTI in Women Post-Electrofulguration

por Kenee, Parker R M, Christie, Alana L, Zimmern, Philippe E
Publicado 2022

Macroplastique for women with stress urinary incontinence secondary to intrinsic sphincter deficiency

por Carroll, Timothy F., Christie, Alana, Foreman, Melissa, Khatri, Gaurav, Zimmern, Philippe E.
Publicado 2019

Value of combined adjuvant chemotherapy and radiation on survival for stage III uterine cancer: is less radiation equal to more?

por Wang, Chiachien Jake, Christie, Alana, Folkert, Michael R., Xie, Xian-Jin, Albuquerque, Kevin
Publicado 2018

PSUN24 Adrenal Metastases Treated with Radiotherapy: Development of Adrenal Insufficiency

por Tumyan, Gayane, Hamidi, Oksana, Christie, Alana, Mifrakhraee, Sasan, Dohopolski, Michael, Gottumukkala, Sujana, Hannan, Raquibul
Publicado 2022

Erratum to: Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma

por Sharma, Akanksha, Elias, Roy, Christie, Alana, Williams, Noelle S., Pedrosa, Ivan, Bjarnason, Georg A., Brugarolas, James
Publicado 2023

Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma(1)

por Sharma, Akanksha, Elias, Roy, Christie, Alana, Williams, Noelle S., Pedrosa, Ivan, Bjarnason, Georg A., Brugarolas, James
Publicado 2022

Empiric versus culture-based antibiotic therapy for UTIs in menopausal women

por Kusin, Samuel B., Fan, Ethan M., Prokesch, Bonnie C., Christie, Alana L., Zimmern, Philippe E.
Publicado 2023

Bacterial Growth of Uropathogenic Escherichia coli in Pooled Urine Is Much Higher than Predicted from the Average Growth in Individual Urine Samples

por Hogins, Jacob, Fan, Ethan, Seyan, Zheyar, Kusin, Sam, Christie, Alana L., Zimmern, Philippe E., Reitzer, Larry
Publicado 2022

Mammographic density changes in surgical weight loss-an indication for personalized screening

por Partain, Natalia, Mokdad, Ali, Puzziferri, Nancy, Porembka, Jessica, Seiler, Stephen, Christie, Alana, Farr, Deborah, Rivers, Aeisha, Marilyn Leitch, A., Wooldridge, Rachel, Huth, James, Rao, Roshni
Publicado 2018

Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type

por Cai, Qi, Christie, Alana, Rajaram, Satwik, Zhou, Qinbo, Araj, Ellen, Chintalapati, Suneetha, Cadeddu, Jeffrey, Margulis, Vitaly, Pedrosa, Ivan, Rakheja, Dinesh, McKay, Renee M., Brugarolas, James, Kapur, Payal
Publicado 2019

Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

por Gayed, Bishoy A, Gillen, Jessica, Christie, Alana, Peña-Llopis, Samuel, Xie, Xian-Jin, Yan, Jingsheng, Karam, Jose A, Raj, Ganesh, Sagalowsky, Arthur I, Lotan, Yair, Margulis, Vitaly, Brugarolas, James
Publicado 2015

High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

por Wolff, Nicholas C., Pavía-Jiménez, Andrea, Tcheuyap, Vanina T., Alexander, Shane, Vishwanath, Mridula, Christie, Alana, Xie, Xian-Jin, Williams, Noelle S., Kapur, Payal, Posner, Bruce, McKay, Renée M., Brugarolas, James
Publicado 2015

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma

por Patel, Viral, Elias, Roy, Formella, Joseph, Schwartzman, William, Christie, Alana, Cai, Qi, Malladi, Venkat, Kapur, Payal, Vazquez, Miguel, McKay, Renee, Pedrosa, Ivan, Hannan, Raquibul, Hammers, Hans, Brugarolas, James
Publicado 2020

Corrigendum to ‘‘Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type’’ [EB...

por Cai, Qi, Christie, Alana, Rajaram, Satwik, Zhou, Qinbo, Araj, Ellen, Chintalapati, Suneetha, Singla, Nirmish, Cadeddu, Jeffrey, Margulis, Vitaly, Pedrosa, Ivan, Rakheja, Dinesh, McKay, Renee M., Brugarolas, James, Kapur, Payal
Publicado 2020

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

por Ho, Thai Huu, Kapur, Payal, Eckel-Passow, Jeanette E., Christie, Alana, Joseph, Richard W., Serie, Daniel J., Cheville, John C., Thompson, R. Houston, Homayoun, Farrah, Panwar, Vandana, Brugarolas, James, Parker, Alexander S.
Publicado 2017

PD-L1 detection using (89)Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response

por Vento, Joseph, Mulgaonkar, Aditi, Woolford, Layton, Nham, Kien, Christie, Alana, Bagrodia, Aditya, de Leon, Alberto Diaz, Hannan, Raquibul, Bowman, Isaac, McKay, Renee M., Kapur, Payal, Hao, Guiyang, Sun, Xiankai, Brugarolas, James
Publicado 2019

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics

por Ocal, Ozhan, Pashkov, Victor, Kollipara, Rahul K., Zolghadri, Yalda, Cruz, Victoria H., Hale, Michael A., Heath, Blake R., Artyukhin, Alex B., Christie, Alana L., Tsoulfas, Pantelis, Lorens, James B., Swift, Galvin H., Brekken, Rolf A., Wilkie, Thomas M.
Publicado 2015

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma

por Schoenhals, Jonathan E., Mohamad, Osama, Christie, Alana, Zhang, Yuanyuan, Li, Daniel, Singla, Nirmish, Bowman, Isaac, Arafat, Waddah, Hammers, Hans, Courtney, Kevin, Cole, Suzanne, Bagrodia, Aditya, Margulis, Vitaly, Desai, Neil, Garant, Aurelie, Choy, Hak, Timmerman, Robert, Brugarolas, James, Hannan, Raquibul
Publicado 2021